Langerhans cells and dendritic cells are cytotoxic towards HPV16 E6 and E7 expressing target cells

Cancer Immunology, Immunotherapy

Volumn 57, Issue 6, 2008, Pages 789-797

  Le Poole, I Caroline ^a   ElMasri, Wafic M ^a   Denman, Cecele J ^a   Kroll, Tara M ^a   Bommiasamy, Hemamalini ^a   Lyons Eiben, Gretchen ^b   Kast, W Martin ^c  

^a LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cervical cancer; Cytotoxicity; Dendritic cells; Langerhans cells; TRAIL; Tumor immunity

Indexed keywords

GAMMA INTERFERON; PROTEIN E6; PROTEIN E7; PROTEIN S 100; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ARTICLE; CELL ASSAY; CELL INFILTRATION; CELL KILLING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOTOXICITY; DENDRITIC CELL; EFFECTOR CELL; EPITHELIUM CELL; FEMALE; GENETIC TRANSFECTION; HOST CELL; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TARGET CELL; TUMOR IMMUNITY; UTERINE CERVIX CANCER;

ANIMALS; APOPTOSIS; DENDRITIC CELLS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; INFLAMMATION; LANGERHANS CELLS; MICE; ONCOGENE PROTEINS, VIRAL; REPRESSOR PROTEINS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UTERINE CERVICAL NEOPLASMS;

EID: 43349087382     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-007-0415-z     Document Type: Article

References (36)

1. Aguilar-Lemarroy A, Gariglio P, Whitaker NJ et al (2002) Restoration of p53 expression sensitizes human papillomavirus type 16 immortalized human keratinocytes to CD95-mediated apoptosis. Oncogene 21:165-175
2. Basile JR, Zacny V, Münger K (2001) The cytokines Tumor Necrosis Factor-α (TNF-α) and TNF-related apoptosis-inducing ligand differentially modulate proliferation and apoptotic pathways in human keratinocytes expressing the human papillomavirus-16 E7 oncoprotein. J Biol Chem 276:22522-22528
3. Cassetti MC, McElhiny SP, Shahabi V et al (2004) Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes. Vaccine 22:520-527
4. Chang AE, Li Q, Bishop DK et al (2005) Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor. Hum Gene Ther 11:839-850
5. Chaudhari BR, Murphy RF, Agrawal DK (2006) Following the TRAIL to apoptosis. Immunol Res 35:249-262
6. Chaperot L, Blum A, Manches O et al (2006) Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 176:248-255
7. Cohen EP, Kim TS (1994) Neoplastic cells that express low levels of MHC class I determinants escape host immunity. Semin Cancer Biol 5:419-428
8. Eiben GL, Velders MP, Schreiber H et al (2002) Establishment of an HLA-A*0201 human papillomavirus type 16 tumor model to determine to determine the efficacy of vaccination strategies in HLA-A*0201 transgenic mice. Cancer Res 62:5792-5799
9. Fanger NA, Maliszewski CR, Scholley K, Griffeth TS (1999) Human dendritic cells mediate apoptosis via cellular apoptosis-inducing ligand (TRAIL). J Exp Med 190:1155-1164
10. Fausch SC, Da Silva DM, Kast WM (2003) Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res 63:3478-3482
11. Feltkamp MC, Smits HL, Vierboom MP et al (1993) Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur J Immunol 23:2242-2249
12. Guan B, Yue P, Clayman GL, Sun SY (2001) Evidence that the death receptor DR4 is a DNA damage-inducible, p53-regulated gene. J Cell Phys 188:98-105
13. Harwood CA, Surentheran T, Sasieni P et al (2004) Increased risk of skin cancer associated with the presence of epidermodysplasia verruciformis human papillomavirus types in normal skin. Br J Dermatol 150:949-957
14. Hougardy BM, Maduro JH, van der Zee AG et al (2006) Proteasome inhibitor MG132 sensitizes HPV-positive cervical cancer cells to rhTRAIL-induced apoptosis. Int J Cancer 118:1892-1900
15. Hunger RE, Sieling PA, Ochoa MT et al (2004) Langerhans cells utilize CD1a and langerin to efficiently present non-peptide antigens to T cells. J Clin Invest 113:701-708
16. Janjic BM, Lu G, Pimenov A et al (2002) Innate direct anticancer effector function of human immature dendritic cells. I. Involvement of an apoptosis-inducing pathway. J Immunol 168:1823-1830
17. Jimenez-Flores R, Mendez-Cruz R, Ojeda-OrtizJ et al (2006) High-risk human papillomavirus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract. Immunology 117:220-228
18. Kayagaki N, Yamaguchi N, Nakayama M et al (1999) Involvement of TNF-related apoptosis-inducing ligand in human T cell-mediated cytotoxicity. J Immunol 162:2639-2647
19. Khorana AA, Rosenblatt JD, Sahasrabudhe DM et al (2003) A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Ther 10:251-259
20. Kissenpfennig A, Ait-Yahia S, Clair-Moninot V et al (2005) Disruption of the langerin/CD207 gene abolishes Birbeck granules without a marked loss of Langerhans cell function. Mol Cell Biol 25:88-99
21. Kumamoto T, Huang EK, Paek HJ et al (2002) Induction of tumor-specific protective immunity by in situ Langerhans cell vaccine. Nat Biotechnol 20:64-69
22. Lin KY, Guarnieri FG, Stavely-O'Carroll KF et al (1996) Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res 56:21-26
23. Lu G, Janjic BM, Janjic J et al (2002) Innate direct anticancer effector function of human immature dendritic cells. II Role of TNF, lymphotoxin-alpha(1) beta(2), Fas ligand, and TNF-related apoptosis-inducing ligand. J Immunol 168:1831-1939
24. Lynch DH (1998) Induction of dendritic cells (DC) by Flt3 ligand (FL) promotes the generation of tumor-specific immune responses in vivo. Crit Rev Immunol 18:99-107
25. Matzinger P (1991) The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 145:185-192
26. McFadden G, Kane K (1994) How DNA viruses perturb functional MHC expression to alter immune recognition. Adv Cancer Res 63:117-209
27. Muderspach L, Wilczynski S, Roman L et al (2000) A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res 6:3406-3416
28. Schuurhuis DH, Fu N, Ossendorp F, Melief CJ (2006) Ins and outs of dendritic cells. Int Arch Allergy Immunol 140:53-72
29. Sedman SA, Barbosa MS, Vass WC et al (1991) The full length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture. J Virol 65:4860-4866
30. Sholl LM, Hornick JL, Pinkus GS, Padera RF (2007) Immunohistochemical analysis of langerin in langerhans cell histiocytosis and pulmonary inflammatory and infectious diseases. Am J Surg Pathol 31:947-952
31. Streilein JW, Bergstresser PR (1984) Langerhans cells:antigen presenting cells of the epidermis. Immunobiol 168:285-300
32. Taube JM, Nichols AD, Bornman LS et al (2007) Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection. J Cutan Pathol 34:565-570
33. Tsutsumi K, Balguli N, Qi S et al (1992) Human Papillomavirus 16 DNA immortalizes two types of normal human epithelial cells of the uterine cervix. Am J Pathol 140:255-261
34. Van der Loos CM, Das PK, Van den Oord JJ, Houthoff HJ (1989) Multiple immunoenzyme staining techniques. Use of fluoresceinated, biotinylated and unlabeled monoclonal antibodies. J Immunol Methods 117:45-52
35. Vidalain PO, Azocat PO, Yagita H et al (2001) Cytotoxic activity of human dendritic cells is differentially regulated by double-stranded RNA and CD40 ligand. J Immunol 167:3765-3772
36. Wentzensen N, Vinokurova S, von Knebel Doeberitz M (2004) Systematic review of genomic integration sites of human papillomavirus genomes in epithelial dysplasia and invasive cancer of the female lower genital tract. Cancer Res 64:3878-3884